Skip Navigation

  1. Acerca de Nosotros
    1. Visión General
    2. Historia
    3. Oficinas
  2. Nuestra Experiencia
    1. Áreas de Trabajo
      1. Patentes
      2. Marcas
      3. Derecho de Autor
      4. Derecho Corporativo y Mercantil
      5. Litigio de Propiedad Intelectual y Resolución Alternativa de Disputas
      6. Práctica Regulatoria
      7. Otorgamiento de Licencias, Transferencia de Tecnología y Franquicias
      8. Anti-Piratería, Anti-Falsificación & Aplicación
    2. Grupos de la Industria
      1. Grupo de Abogados en Medios, Deportes y Entretenimiento
      2. Grupo de Abogados e Ingenieros en Ciencias de la Vida
  3. Nuestra Gente
    1. Socios
      1. Sergio L. Olivares, Sr. † (1931-2010)
      2. Sergio L. Olivares, Jr.
      3. Luis C. Schmidt
      4. César Ramos, Jr.
      5. Antonio Belaunzarán
      6. Gustavo A. Alcocer
      7. Alejandro Luna
      8. Alonso Camargo
      9. Daniel Sánchez
    2. Asociados (A - M)
      1. Osvaldo Amaral
      2. Armando Arenas
      3. Sofía Arroyo
      4. Guillermo Ballesteros
      5. Abraham Diaz
      6. Georgina Flores
      7. Pedro Herrera
    3. Asociados (N - Z)
      1. Mauricio Narváez
      2. Víctor Ramírez
      3. Sergio Rangel
      4. Maria del Carmen Sada
      5. Juan Luis Serrano
      6. Guillermo Treviño
    4. Abogados / Ingenieros
      1. Emilio Albarrán
      2. Agustín Azcatl
      3. Alejandra Badillo
      4. Ignacio Burgoa
      5. Fernando Calderón
      6. Martha Celis
      7. Erwin Cruz
      8. Fernanda Díaz
      9. Maria Fenton
      10. Luz Elena Elías
      11. 15 more items...
    5. Administración de la firma
    6. Directorio
  4. Conocimiento & Recursos
    1. Artículos y Estudios de Casos
      1. Artículos sobre Marcas
        1. International Comparative Legal Guide: Trademarks 2013
        2. Errores en las solicitudes de marcas
        3. La Suprema Corte: todo inidividuo puede registrar una marca
        4. Use requirements
        5. Approach to composite marks changed, again
        6. Life Sciences Handbook 2011 - Country Q&A
        7. Mexico should accept secondary meaning
        8. Getting the Deal Through - Trademarks 2011
        9. Pharmaceutical Trademarks 2010/2011 - A Global Guide
        10. No legal basis for banning names derived from INNs
        11. 46 more items...
      2. Artículos sobre Patentes
        1. Ampliación de la Protección de Diseños Industriales
        2. Mexican Linkage Gazette April 2011
        3. Mexico issues regulations to approve biologic drugs
        4. Latin America Roundtable
        5. New regulations pending
        6. The International Comparative Guide
        7. Marketing authorization for pharmaceutical
        8. Approval of follow-on biologics in Mexico
        9. Patent Prosecution Highway in Mexico
        10. Life Sciences Handbook 2011 - Country Q&A
        11. 36 more items...
      3. Artículos sobre Derecho de Autor
        1. Publicidad en redes sociales
        2. Technology challenges digital rights
        3. Exceptions to copyright protection and the permitted uses of copyright works in the hi-tech and digital sectors
        4. Derechos sobre producción audiovisual
        5. How Latin America tackles cutting-edge IP issues
        6. Copyright Litigation 2010
        7. Legislation and enforcement - Copyrights 2010
        8. Valuing folklore
        9. Protecting novel ideas
        10. Mexico's fair use balancing act
        11. 97 more items...
      4. Artículos sobre Derecho Corporativo
        1. Mexico issues Personal Data Protection Rules
        2. A practical cross-border
        3. New registry for security interests
        4. The International Comparative Legal Guide to: Merger Control 2011
        5. The International Comparative Legal Guide to: Merger Control 2010
        6. Due diligence issues to consider in M&A
        7. Income expectations in licensing
        8. The reasons for valuation
        9. Amendments proposed to franchise regulation
      5. Artículos sobre Litigio y RAD
        1. Scope of new specialised courts widened
        2. Reform of preliminary injunctions
        3. Mexican Patent Office excludes Formulation Patents from Linkage Gazette
        4. Mexico gets ready to approve biocomparable drugs
        5. Mexico's hotel for the stars highlights power in the name
        6. Supreme Court upholds the worth of formulation patents
        7. Getting the Deal Through - Patents 2010
        8. Getting the Deal Through Trademarks 2010
        9. Trademark enforcement
        10. Venues for appealing IMPI decisions
        11. 15 more items...
      6. Artículos sobre Derecho Regulatorio
        1. La NOM 257 modifica el sistema de vinculación de patentes de medicamentos en México
        2. Recientes enmiendas a la Ley Federal de Protección al Consumidor
        3. Enmiendas en la Ley Federal de Protección al Consumidor
        4. Mexico issues Personal Data Protection Rules
        5. New Regulations Pending
        6. Marketing authorization for pharmaceutical products to foreign applicants
        7. Data Package Exclusivity (DPE)
        8. Supreme Court upholds the worth of formulation patents
        9. Pharmaceutical trademarks
        10. Framework for biotherapeutic products established
        11. 5 more items...
      7. Artículos sobre Licencias y Transferencia de Tecnología
        1. Creating a secure franchise system
      8. Artículos sobre Anti-piratería y Anti-falsificación
        1. New register against counterfeits
        2. Beat the counterfeiters in Mexico
        3. Battling counterfeits through Customs
        4. Getting the Deal Through Trademarks 2010
        5. Enforcing plant variety rights in Mexico
        6. Pharmaceutical Trademarks 2009
        7. Internet Issues
        8. Anti-counterfeiting 2009
        9. Vegetal variety rights enforced
        10. New Customs rules lead to seizures
        11. 4 more items...
      9. Artículos en relación con Medios, Deportes y Entretenimiento
        1. Publicidad en redes sociales
        2. Whither Rental Rights?
        3. Improved protection for personalities
      10. Artículos en relación con Ciencias de la Vida
        1. Latin America Roundtable
        2. New regulations pending
        3. The International Comparative
        4. Approval of follow-on biologics in Mexico
        5. Global Pharmaceutical Linkage Regulations:
        6. Life Sciences Handbook 2011 - Country Q&A
        7. Supreme Court upholds the worth of formulation patents
        8. Repercussions expected on medicine advertising campaign in Mexico
        9. Framework for biotherapeutic products established
        10. Pharmaceutical Trademarks 2009
        11. 1 more item...
    2. Noticias
      1. La Propiedad Intelectual en el Entorno Digital
      2. Intellectual Property: Past & Future
      3. Iniciativa de ley para reducir la vigencia de patentes de medicamentos
      4. Entrevista a Alejandro Luna sobre "La Innovación y biotecnología"
      5. México firma el Acuerdo Comercial Anti-falsificación (ACTA)
      6. Modificaciones a la Ley de Propiedad Intelectual
      7. Se realizan enmiendas a la Ley Federal de Protección al Consumidor
    3. Gacetas
      1. Mexican Linkage Gazette March 2013
      2. Mexican Linkage Gazette December 2012
      3. Mexican Linkage Gazette November 2012
      4. Mexican Linkage Gazette December 2011
      5. Mexican Linkage Gazette April 2011
  5. Oficinas
  6. Eventos
  7. Contacto

Español » Conocimiento & Recursos » Artículos y Estudios de Casos » Artículos sobre Litigio y RAD » Venues for appealing IMPI decisions

Venues for appealing IMPI decisions

por Daniel Sánchez, Managing Intellectual Property, International Briefings, April 2009.
Since 2000, the proper venues in which to challenge decisions from IMPI included the review recourse proceeding before IMPI itself and/or the nullity trial before the Federal Court for Tax and Administrative Affairs (FCTAA).
Last year, the Supreme Court, through a jurisprudence that is mandatory for all court systems, added the constitutional trial known as an "amparo suit" to the traditional venues of appeal.
In light of such jurisprudence, a decision from IMPI can now be appealed via three options, with the following general characteristics:
Review recourse: IMPI's officers usually confirm the decisions of the inferior officers. Thus this venue is not commonly recommended, unless there has been a clear mistake by the authority. The resolutions issued can be further appealed in two additional stages.
Nullity trial: The nullity trial is brought before the FCTAA, the Court with original jurisdiction to review appeals against decisions issued by administrative authorities such as IMPI. This Court has a specialised court for IP matters that began operating on January 5 2009.
The FCTAA has full jurisdiction to review the case de novo , which implies that the merits of the case will be reviewed. Also, the stay that this Court is able to grant could have beneficial effects. However, the Court is severely backlogged, which implies long periods of time before obtaining a decision and subsequent compliance by IMPI. The decisions of the FCTAA can be appealed before a Circuit Court.
Amparo suit: The advantages of this venue are that, due to requirements of the procedural law, cases are decided in a shorter time frame, ranging from 2-5 months, with stays being instituted very quickly, within a 2 day period after filing of a suit.
The main disadvantage is that, under the Amparo law, the Judge is bound to first find the clear error in the decision under review and is not entitled to review the case de novo. Thus, many of the decisions in Amparo suits are remanded to IMPI for further consideration, with certain guidelines that may be concerned mainly with the due process of law. The decisions of the District Court can be appealed before a Circuit Court.